Cancer Biology Seminar Series
Tuesdays, 12:00-1:00 PM
Munzer Auditorium, Beckman Center/ALWAYM106/Clark Center
October 1 Munzer Auditorium
Lewis Cantley, Ph.D.
Harvard Medical School
“A technology for identifying protein kinases driving disease states"
October 15 Munzer Auditorium
Dohoon Kim, Ph.D.
UMass Chan Medical School
“Uncovering and exploiting toxic metabolite pathways in cancer cells”.
Elham Azizi, Ph.D.
Columbia University
"Machine learning for modeling cellular dynamics in the tumor microenvironment".
December 10 ALWAYM106
Paul Northcott, Ph.D.
St. Jude Children's Research Hospital
”Dissecting developmental drivers & druggable dependencies in embryonal CNS tumors”
January 21 ALWAYM106
Valerie Weaver, Ph.D.
University of California San Francisco
"Tissue tension regulates inflammation to drive tumor initiation and progression"
February 4 ALWAYM106
Steven Artandi, M.D., PhD.
Stanford University School of Medicine
Director of The Stanford Cancer Institute
"Clone wars, telomerase, and cancer"
February 11 Munzer Auditorium
Karuna Ganesh, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
“Dissecting and targeting cancer plasticity”
March 4 ALWAYM106
Laura Wood, M.D., Ph.D.
Johns Hopkins Medicine
"Genomic and Spatial Analyses of Human Pancreatic Precancers".
March 18 Clark Center S360
Kevan Shokat, Ph.D.
University of California San Francisco
"Overcoming the undruggable nature of the most common human oncogene K-Ras"
April 1 Clark Center Auditorium Soo1
Theo Ross, M.D., PhD.
AbbVie
"Cancer Therapy Innovations: Basic Science, Patients, Biopharma, and Luck"
April 15 Clark Center 360
Alberto Ciccia, Ph.D.
Columbia University Medical Center
“CRISPR-based approaches to study the DNA damage response”
May 13 Clark Center S360
Núria López-Bigas, Ph.D.
Institute for Research in Biomedicine, Barcelona
"TBD"
October 3 Munzer Auditorium
Eyal Gottlieb, Ph.D.
University of Texas MD Anderson Cancer Center
"Exploiting Metabolic Liabilities of Cancer Cells"
October 17 Munzer Auditorium
Aaron Diaz, Ph.D.
University of California San Francisco
"Single-cell genomics studies of brain-tumor heterogeneity"
November 14 Munzer Auditorium
Agata Smogorzewska MD., Ph.D.
The Rockefeller University
"When Watson and Crick Get Linked: DNA Interstrand Crosslink Repair and tumorigenesis"
November 28 Munzer Auditorium
Alexander Wyatt, Ph.D.
The University of British Columbia
"Circulating tumor DNA in metastatic prostate cancer "
December 12 Munzer Auditorium
Benjamin F. Cravatt, Ph.D.
The Scripps Research Institute
"Activity-based proteomics-target and ligand discovery on a global scale"
CANCELED: January 16 Munzer Auditorium
This Event is Canceled.
Lewis C. Cantley, Ph.D.
Harvard Medical School
"An Atlas of the Substrate Specificity of All Human Protein-Tyrosine Kinases"
January 30 Munzer Auditorium
W. Kimryn Rathmell, MD. Ph.D.
Vanderbilt University
Director of the National Cancer Institute
"Supply and Demand: Metabolic forces in the Tumor Environment"
Vishaka Gopalan, Ph.D.
Postdoctoral Fellow
National Cancer Institute
"Edge cell states in pancreatic cancer initiation"
February 27 Munzer Auditorium
Mariella Filbin, MD. Ph. D.
Dana Farber Cancer Institute
"Targeting intra-tumoral heterogeneity and developmental pathways in pediatric High-Grade Glioma"
March 12 Munzer Auditorium
Boyi Gan, Ph.D.
MD Anderson Cancer Center
"Targeting Ferroptosis and Disulfidptosis in Cancer"
April 2 Munzer Auditorium
Angela Koehler, Ph.D.
Massachusetts Institute of Technology
"Attenuating Oncogenic Transcription with Small Molecules"
April 23 Munzer Auditorium
Luke Gilbert, Ph.D.
University of California San Francisco
"CRISPR approaches for studying genes and drugs"
April 30 Munzer Auditorium
Mario Suva, MD., Ph.D.
Harvard Medical School and Massachusetts General Hospital
"Single-cell genomic analysis of gliomas in space and time"
May 7 Munzer Auditorium
Salman Banani, MD.,Ph.D.
The University of Chicago
"Biomolecular Condensates: Emergent Properties and Dysregulation in Disease"
May 21 Munzer Auditorium
Vanessa Dumeaux, Ph.D.
Western University
“From Genes to Microbes: Multidimensional Approaches for Predicting Breast Cancer Therapy Responses”
June 4 Munzer Auditorium
Alice Berger, Ph.D.
Fred Hutch Cancer Center
"Understanding the cancer genome to enable precision medicine"
October 4 Munzer Auditorium
Rugang Zhang, Ph.D.
The Wistar Institute
"Epigenetic approaches to epithelial ovarian cancer"
October 11 Munzer Auditorium
Jean Cook, Ph.D.
"Cell cycle dynamics that ensure genome stability"
October 18 Munzer Auditorium
David Raulet, Ph.D.
"Natural killer cells and their receptors in cancer surveillance and immunotherapy"
October 25 Stanford Zoom
https://stanford.zoom.us/j/91999297895?
pwd=MkVUZkhsU1oweUJlVEdoN1Z2OTZOZz09
Password: 898989
Eli Van Allen, M.D.
November 1 Munzer Auditorium
Oana Ursu, Ph.D. Postdoctoral Fellow
"Using Perturb-seq to study cancer drivers: from coding variants to chromatin remodeling complexes"
November 15 Munzer Auditorium
Sabrina L. Spencer, Ph.D.
"TRapid escape from quiescence induced by targeted MAPK pathway inhibitors"
November 29, 2022 Stanford Zoom
https://stanford.zoom.us/j/91999297895?
pwd=MkVUZkhsU1oweUJlVEdoN1Z2OTZOZz09
Password: 898989
Philip Jones, Ph.D
Wellcome Sanger Institute
"How pro- and anti- oncogenic mutants colonize normal epithelia"
December 6, 2022 Munzer Auditorium
Benjamin Tu, Ph.D.
UT Southwestern Medical Center
"Fundamental Functions of TORC1 and roles in tumorigenesis"
January 10, 2023 Munzer Auditorium
Josua Mendell, M.D., Ph.D.
UT Southwestern Medical Center
"New functions for noncoding RNAs in mammalian cells"
January 17, 2023 Stanford Zoom https://stanford.zoom.us/j/91999297895?pwd=MkVUZkhsU1oweUJlVEdoN1Z2OTZOZz09
Password: 898989
Sarah-Maria Fendt, Ph.D.
VIB-KU LEUVEN Center for Cancer Biology
"Metabolic rewiring driving metastasis formation"
January 24, 2023
Munzer Auditorium
Jared Rutter, Ph.D.
University of Utah School of Medicine
"Metabolism, Cellular Decisions and the Language That Unites Them"
January 31, 2023
Munzer Auditorium
Lauren A. Byers, M.D.
The University of Texas, MD Anderson Cancer Center
"From black-and-white to Technicolor: New Opportunities for Precision Medicine in Small Cell Lung Cancer"
February 28, 2023
Munzer Auditorium
Diana Hargreaves, Ph.D.
Salk Institute for Biological Studies
“Remodeling the Chromatin Landscape: SWI/SNF Complexes in Development and Disease”
March 14, 2023
Munzer Auditorium
Oscar Aguilar Alfaro, Ph.D.
Postdoctoral Scholar, UCSF
“Targeting cancer using natural killer cells”
April 25, 2023
Munzer Auditorium
Jing Chen, Ph.D.
The University of Chicago
“Nutrients, Metabolism, and Cancer”
September 21
Stanford Zoom
Jason D. Buenrostro, Ph.D.
Harvard University
"Seminar Single-cell Epigenomics: Gene regulation at unprecedented resolution"
October 5
LKSC 130
Joshua Rabinowitz, M.D., PhD.
Princeton University
"Cancer, metabolism, and diet"
October 19
Stanford Zoom
Benjamin L. Ebert, M.D., Ph.D.
Dana-Farber Cancer Institute - Harvard Medical School
"Targeted protein degradation for the treatment of cancer."
November 2
Stanford Zoom
Mario L. Suva, M.D., Ph.D.
Massachusetts General Hospital
"Dissecting the biology of human gliomas by single-cell genomics"
November 16
LKSC 130
Vera Gorbunova, Ph.D.
University of Rochester
"Mechanisms of longevity: from naked mole rats to whales"
November 30
Alway M106
Erinn Rankin, Ph.D.
Stanford University
"The RNA demethylase FTO is a therapeutic target that couples metabolic reprogramming and gene expression to support tumor growth and survival"
January 11
Stanford Zoom
Chuan He, Ph.D.
University of Chicago
"Gene expression regulation by RNA methylation and demethylation"
January 25
Beckman Munzer Auditorium
E. Alejandro Sweet-Cordero, MD.
University of California, San Francisco
"New approaches to targeting Ras-driven cancers"
February 15
Beckman Munzer Auditorium
Lydia Finley, Ph.D.
Memorial Sloan Kettering Cancer Center
"Metabolic regulation of cell fate decisions."
March 1
Stanford Zoom
Owen Witte, M.D.
University of California, Los Angeles
"Convergent evolution to a stem cell phenotype in epithelial cancers"
March 8
Munzer Auditorium Beckman Center
David Kirsch, M.D., Ph.D.
Duke Cancer Institute
"Mechanisms of sarcoma response to radiation and immunotherapy"
October 13
Calvin Kuo, M.D., Ph.D.
Stanford University
"Studying Cancer with Vascular Biology, Stem Cells, and Organoids"
October 27
Robert Weinberg, Ph.D.
Massachusetts Institute of Technology
"Effects of Epithelial-Mesenchymal Polarization on Carcinoma Cell Biology"
January 5
9:00 am
Geneviève Almouzni, Ph.D.
Institut Curie Research Center
"Histone H3 variants and chaperones: roles in cell fate from normal to disease state"
January 19
9:00 am
Hans Clevers, M.D., Ph.D.
Hubrecht Institute
“Organoids to model human disease”
February 23
Gina DeNicola, Ph.D.
Moffitt Cancer Center
“Metabolic rewiring by NRF2 in lung cancer: tumor-promoting or antagonistic?”
March 2
Kathryn Wellen, Ph.D.
University of Pennsylvania
“Metabolic adaptations to nutrient deprivation or excess”
March 9
Johanna Joyce, Ph.D.
University of Lausanne Ludwig Institute for Cancer Research
“Exploring and Therapeutically Exploiting the Tumor Microenvironment”
April 20
Donita Brady, Ph.D.
Perelman School of Medicine University of Pennsylvania
“Copper Dependent Kinases: Making Every Penny Count in Cancer”
May 4
Ashani Weeraratna, Ph.D.
John Hopkins School of Medicine
“Age against the machine: How the homeostasis of cancer is disrupted by aging”
May 18
Francisco Sanchez-Rivera, Ph.D.
Postdoctoral Researcher
Memorial Sloan Kettering Cancer Center
“Deconstructing cancer using mouse models and genome engineering”
May 25
John Carpten, Ph.D.
Keck School of Medicine
University of Southern California
“The Impact of Heterogeneity in Cancer Genome Science”
June 1
Susan Kaech, Ph.D.
Keck School of Medicine
Salk Institue for Biological Studies
“Overcoming Tumor Resistance to Immunotherapies”
MONDAY, September 23
Xin Lu, Ph.D.
Oxford University
"Cellular Plasticity and Upper GI Cancers"
October 15
Hannah Carter, Ph.D.
University of California, San Diego
"MHC Genotype Shapes the Oncogenic Mutational Landscape"
October 22
Howard Chang, M.D., Ph.D.
Stanford University
"Personal Regulome Navigation of Cancer"
November 5
Karen Cichowski, Ph.D.
Harvard University
"Developing Therapies for Ras Driven Cancers"
December 10
Laura Fejerman, Ph.D.
University of California, San Francisco
"Subtype-Specific Breast Cancer Risk in Highly Indigenous Latin American Women"
January 14
Aimee Edinger, VMD, Ph.D.
University of California, Irvine
"Starving Cancer Cells to Death by Limiting their Access to Nutrients"
January 21
Christine Mayr, Ph.D.
Memorial Sloan Kettering
"Regulation of Protein Functions by 3' UTRs"
February 11
David Bilder, Ph.D.
University of California, Berkeley
"Cold-Blooded Cancer"
February 25
Kristian Helin, Ph.D.
Memorial Sloan Kettering
"Epigenetics, Transcription, and Cancer"
CANCELLED
March 10
Agata Smogorzewska, M.D., Ph.D.
Rockefeller University
"Mechanism of DNA Repair during Replication"
CANCELLED
March 24
Mario Suva, M.D., Ph.D.
MGH/Harvard
"An Integrative Model of Single-Cell States and Genetics for Glioblastoma"
CANCELLED
April 14
Owen Witte, M.D.
University of California, Los Angeles
"Convergent Evolution to a Stem Cell Phenotype in Epithelial Cancers"
CANCELLED
MAY 5
Sumin Kang, Ph.D.
Emory University
"Targeting Cancer Signaling Nodes to Overcome Chemotherapy Resistance"
CANCELLED
MAY 26
Sylvia Plevritis, Ph.D.
Stanford University
"Reconstructing the Tumor Microenvironment Through Multi-Omic Analysis"
October 2, 2018
Capucine Van Rechem, PhD
Stanford University
"Understanding Chromatin Modifiers Contribution to Diseases through Cell Cycle and Unconventional Roles"
October 23, 2018
NEW TIME: 4-5 PM
NEW LOCATION: LKSC, Berg Hall
John Minna, MD
University of Texas Southwestern Medical Center
"Identifying and Targeting Lung Cancer Vulnerabilities"
November 13, 2018
NEW LOCATION: SIM 1/G1002
Hao Zhu, MD
University of Texas Southwestern Medical Center
"Interrogating the Genomics of Liver Regeneration and Liver Cancer with Mouse Models"
December 4, 2018
January 15, 2019
January 29, 2019
Sandra Horning, MD
Genentech
"The arduous and ever exciting journey
From molecules to innovative medicines at Genentech"
February 19, 2019
Valerie Weaver, PhD
University of California, San Francisco
"Forcing Tumor Progression and Metastasis"
CANCELLED
March 5, 2019
Location: Clark Center Auditorium
Mario Suva, MD, PhD
Harvard Medical School
Massachusetts General Hospital
"Dissecting Pediatric and Adult Gliomas by Single-cell Genomics"
March 26, 2019
April 23, 2019
Christina Curtis, PhD, MSc
Stanford University
"Delineating the Determinants and Dynamics of Metastasis"
May 7, 2019
Matthew Meyerson, MD, PhD
Harvard Medical School and Broad Institute
"Genomic and Functional Studies of Human Lung Cancers"
May 21, 2019
Catherine Wu, MD
Harvard Medical School and Dana-Farber Cancer Institute
"Building Personal Neoantigen-targeting Vaccines for Cancer"
July 11, 2017
START TIME: 12:30 PM
Aug 29, 2017
Laurent Le Cam, PhD
Montpellier Cancer Center, INSERM, France
“Roles of the p53 Pathway in Metabolism: Implications in Aging, Tissue Homeostasis and Carcinogenesis”
Oct 10, 2017
Sohail Tavazoie, MD, PhD
Rockefeller University
“Small-RNAs as Molecular Probes and Therapeutic Guides of Cancer Metastasis”
Oct 24, 2017
Nov 14, 2017
David Gius, MD, PhD
Northwestern University
“The Dysregulation of the SIRT3-MnSOD-Ac Axis in Luminal B Breast Malignancies"
Dec 5, 2017
Paul Mischel, MD, PhD
University of California, San Diego
“In Cancer, as in Real Estate, Location Matters – the Role of Extrachromosomal Oncogene Amplification in Cancer"
Jan 8, 2018
Caroline Dive, PhD
Cancer Research UK Manchester Institute
“Circulating Tumour Cells in SCLC - what do they reveal?"
Jan 16, 2018
Jan 23, 2018
Feb 6, 2018
Kun-Liang Guan, PhD
University of California, San Diego
“The Hippo Pathway in Cell Growth, Organ Size, and Cancer"
Feb 20, 2018
Mar 6, 2018
Jennifer Cochran, PhD
Stanford University
“Engineered Proteins as Next-generation Cancer Therapeutics"
Apr 10, 2018
Elsa Flores, PhD
Moffitt Cancer Center
“p53 Family Regulation of Non-coding RNAs in Cancer Metastasis"
CANCELLED
Apr 24, 2018
Angelika Amon, PhD
Massachusetts Institute of Technology
"Aneuploidy and Cancer - a Complicated Relationship"
Special Seminar
May 10, 2018 at 3PM
Location: Berg Hall A, LKSC
Siddhartha Mukherjee, MD, DPhil
"Thinking outside cancer’s box: metabolism, microenvironment, cells”
CANCELLED
May 15, 2018
July 26, 2016
START TIME: 12:15 PM
Ute Moll, MD
Stony Brook University
“TAp73 is a Master Transcriptional Regulator of Airway Multiciliogenesis”
AUGUST 10, 2016 (WEDNESDAY)
LOCATION: SHRIRAM 104
Joan Brugge, PhD
Harvard Medical School
"Dissecting Functional Heterogeneity of Clonal Populations Derived from Breast and Ovarian Tumors"
AUGUST 26, 2016 (FRIDAY)
Trudy Oliver, PhD
Huntsman Cancer Institute
“Sox2 and Myc: a ‘Tail’ of Two Transcription Factors in Lung Cancer”
OCTOBER 4, 2016
Andreas Strasser, PhD
The Walter and Eliza Hall Institute
"How Does the Tumor Suppressor p53 Protect Us from Developing Cancer?
November 1, 2016
Erica Jackson, PhD
Genentech
"Exploring the Interplay Between Differentiation State and Oncogenic Dependencies in Cancer"
November 15, 2016
Davide Ruggero, PhD
University of California San Francisco
“Translating the Cancer Genome One Codon at a Time and its Therapeutic Implications"
December 6, 2016
Cory Abate-Shen, PhD
Columbia University
“Of Mice and Men: Using Systems Biology Analysis of Mouse Models to Study Human Cancer”
December 13, 2016
Robert Vonderheide, MD, DPhil
University of Pennsylvania
“Mechanisms of Immune Surveillance of Cancer”
January 17, 2017
Sean Morrison, PhD
The University of Texas Southwestern
“Metabolic Regulation of Stem Cells and Cancer”
February 7, 2017
Matthew Vander Heiden, MD, PhD
Massachusetts Institute of Technology
“Role of Altered Metabolism in Tumor Growth”
February 21, 2017
CANCELLED
David Gius, MD, PhD
Northwestern University
“The Dysregulation of the SIRT3-MnSOD-Ac Axis in Luminal B Breast Malignancies”
March 7, 2017
Kimberly Stegmaier, MD
Harvard Medical School
"Integrative Omics to Identify New Cancer Therapeutic Targets"
April 14, 2017
FRIDAY, 11:00 AM
April 18, 2017
NEW START TIME: 12:30 PM
Reuben Shaw, PhD
Salk Institute for Biological Studies
“The LKB1 – AMPK Pathway: Metabolic Rewiring and Therapeutic Windows”
May 2, 2017
Helen Piwnica-Worms, PhD
The University of Texas MD Anderson Cancer Center
"Characterizing and Targeting Primary and Metastatic Triple Negative Breast Cancer”
OCTOBER 6, 2015
Dana Pe'er
Columbia University - Biologicial Sciences
"Exploring cancer heterogeneity: state transitions and microenvironment"
December 15, 2015
LOCATION: CLARK CENTER AUDITORIUM
Carla Kim
Children's Hospital Boston & Harvard Medical School, Department of Genetics
"Lung stem cell approaches to understanding differentiation, disease and therapy"
February 2, 2016
Ralph DeBerardinis
University of Texas - Southwestern Medical Center
"Understanding metabolic phenotypes in cancer cells and tumors"
March 15, 2016
Andrea Ventura
Memorial Sloan Kettering Cancer Center
"Somatic genome editing for in vivo cancer modeling"
April 26, 2016
Bradley Bernstein
Massachusetts General Hospital Cancer Center
"Cancer stem cells and drug resistance in glioblastoma"
May 10, 2016
Michael H. Sieweke
Stem Cell and Macrophage Biology, Centre d'Immunologie de Marseille-Luminy Campus de Luminy
"Stem cell like self renewal in normal differentiated cells without tumorigenic transformation”
May 17, 2016
Events
Stanford University School of Medicine
279 Campus Drive WestStanford, CA 94305